Latest FDA Developments Shaping Clinical Trials in 20252026 BREAKING NEWS: FDA Announces Change in Status of 12 Peptides. For future updates like this, education, training, and support, visit the ssrpinstitute.org and explore what the SSRP community has to offer. Links The FDA's Current Position on Peptides Explained Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York A federal review is underway that could reclassify 14 peptides into FDA Category 1. This change that may influence how peptide therapies are accessed in the U.S. Here's what experts are